Bile Duct Cancer Clinical Trials

• DX-8951f in Treating Patients With Biliary Cancer
  ClinicalTrials.gov Identifier: NCT00005938 - Active, not recruiting
  localized gallbladder cancer; cholangiocarcinoma of the gallbladder; localized extrahepatic bile duct cancer; recurrent gallbladder cancer; ...
  
• Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00101036 - Active, not recruiting
  adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer; unresectable extrahepatic bile duct cancer; ...
  
• 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Biliary Duct or Gallbladder Cancer
  ClinicalTrials.gov Identifier: NCT00075504 - Recruiting
  unresectable extrahepatic bile duct cancer; recurrent gallbladder cancer; unresectable gallbladder cancer; recurrent extrahepatic bile duct cancer; ...
  
• Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas
  ClinicalTrials.gov Identifier: NCT00003923 - Active, not recruiting
  Bile Duct Cancer; Gallbladder Cancer; Pancreatic Cancer
  
• Lapatinib in Treating Patients With Unresectable Liver or Biliary Tract Cancer
  ClinicalTrials.gov Identifier: NCT00107536 - Active, not recruiting
  adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer; unresectable extrahepatic bile duct cancer; ...
  
• Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct
  ClinicalTrials.gov Identifier: NCT00010088 - Active, not recruiting
  adenocarcinoma of the extrahepatic bile duct; stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; ...
  
• Study to Test the Benefit and Safety of DAVANAT in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00386516 - Recruiting
  Cancer of the Bile Duct; Gallbladder Cancer
  
• Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer
  ClinicalTrials.gov Identifier: NCT00033462 - Active, not recruiting
  adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer
  
• Bortezomib as First-Line Systemic Therapy in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder
  ClinicalTrials.gov Identifier: NCT00085410 - Recruiting
  adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer
  
• Efficacy of Double Wire Technique in Difficult Cases of Common Bile Duct Cannulation in ERCP (UDOGUIA-04)
  ClinicalTrials.gov Identifier: NCT00270868 - Active, not recruiting
  Bile Duct Diseases
  
• Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00478140 - Recruiting
  Extrahepatic Bile Duct Cancer; Gallbladder Cancer
  
• Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer
  ClinicalTrials.gov Identifier: NCT00003296 - Active, not recruiting
  recurrent adult primary liver cancer; localized gallbladder cancer; advanced adult primary liver cancer; cholangiocarcinoma of the gallbladder; ...
  
• Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00253617 - Not yet recruiting
  Cholangiocarcinoma of the Extrahepatic Bile Duct; Cholangiocarcinoma of the Gallbladder; Unresectable Extrahepatic Bile Duct Cancer; ...
  
• Gemcitabine and Capecitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Gallbladder Cancer or Cholangiocarcinoma
  ClinicalTrials.gov Identifier: NCT00033540 - Active, not recruiting
  extrahepatic bile duct cancer; Gallbladder Cancer
  
• Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer
  ClinicalTrials.gov Identifier: NCT00030511 - Active, not recruiting
  localized resectable adult primary liver cancer; recurrent adult primary liver cancer; localized extrahepatic bile duct cancer; ...
  
• Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder
  ClinicalTrials.gov Identifier: NCT00084942 - Active, not recruiting
  cholangiocarcinoma of the gallbladder; recurrent gallbladder cancer; unresectable gallbladder cancer; ...
  
• Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction
  ClinicalTrials.gov Identifier: NCT00280709 - Recruiting
  Bile Duct Obstruction; Pancreatic Cancer; Gallbladder Cancer; Bile Duct Cancer
  
• BMS-247550 in Treating Patients With Liver or Gallbladder Cancer
  ClinicalTrials.gov Identifier: NCT00023946 - Active, not recruiting
  adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer
  
• Paclitaxel Eluting Covered Metalic Stent for Uresectable Malignant Bile Duct Obstruction
  ClinicalTrials.gov Identifier: NCT00453076 - Recruiting
  Bile Duct Obstruction
  
• Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer
  ClinicalTrials.gov Identifier: NCT00003557 - Active, not recruiting
  recurrent adult primary liver cancer; advanced adult primary liver cancer; cholangiocarcinoma of the gallbladder; ...
  
• Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer
  ClinicalTrials.gov Identifier: NCT00073905 - Active, not recruiting
  adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer; Pain
  
• Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
  ClinicalTrials.gov Identifier: NCT00059865 - Active, not recruiting
  advanced adult primary liver cancer; unresectable gallbladder cancer; unresectable extrahepatic bile duct cancer; ...
  
• Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer
  ClinicalTrials.gov Identifier: NCT00544193 - Active, not recruiting
  Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Pancreatic Cancer; Small Intestine Cancer
  
• Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
  ClinicalTrials.gov Identifier: NCT00009893 - Active, not recruiting
  recurrent adult primary liver cancer; advanced adult primary liver cancer; recurrent gallbladder cancer; unresectable gallbladder cancer; ...
  
• Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma
  ClinicalTrials.gov Identifier: NCT00238212 - Active, not recruiting
  Extrahepatic Bile Duct Cancer; Gallbladder Cancer
  
• Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas
  ClinicalTrials.gov Identifier: NCT00019513 - Active, not recruiting
  Colorectal Cancer; Esophageal Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer; Lung Cancer; Lymphoma; Pancreatic Cancer; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer
  ClinicalTrials.gov Identifier: NCT00363584 - Recruiting
  Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer
  
• AZD6244 in Treating Patients With Biliary Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00553332 - Recruiting
  Extrahepatic Bile Duct Cancer; Liver Cancer
  
• Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer
  ClinicalTrials.gov Identifier: NCT00005997 - Completed
  adult primary liver cancer; cholangiocarcinoma of the extrahepatic bile duct; cholangiocarcinoma of the gallbladder; ...
  
• Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers
  ClinicalTrials.gov Identifier: NCT00183846 - Recruiting
  Pancreatic Cancer; Gastric Cancer; Duodenum Cancer; Bile Duct Cancer
  
• HAI Via Interventionally Implanted Port Catheter Systems
  ClinicalTrials.gov Identifier: NCT00356161 - Recruiting
  Colorectal Cancer; Liver Neoplasms; Hepatocellular Carcinoma; Gallbladder Cancer; Bile Duct Cancer
  
• Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00486356 - Recruiting
  Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Liver Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Bevacizumab and Erlotinib in Treating Patients With Metastatic or Unresectable Biliary Tumors
  ClinicalTrials.gov Identifier: NCT00356889 - Recruiting
  Extrahepatic Bile Duct Cancer; Gallbladder Cancer
  
• Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00304135 - Recruiting
  Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer
  
• Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor
  ClinicalTrials.gov Identifier: NCT00021047 - Active, not recruiting
  Esophageal Cancer; Extrahepatic Bile Duct Cancer; Gastric Cancer; Head and Neck Cancer; Liver Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer
  ClinicalTrials.gov Identifier: NCT00266097 - Recruiting
  Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Pancreatic Cancer
  
• Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors
  ClinicalTrials.gov Identifier: NCT00262769 - Recruiting
  Extrahepatic Bile Duct Cancer; Gallbladder Cancer
  
• Biomarkers and Radiation Side Effects in Patients Undergoing Radiation Therapy for Gastrointestinal Cancer
  ClinicalTrials.gov Identifier: NCT00452946 - Recruiting
  Colorectal Cancer; Esophageal Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Gastrointestinal Complications; Liver Cancer; Pancreatic Cancer; Radiation Toxicity
  
• Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
  ClinicalTrials.gov Identifier: NCT00582647 - Recruiting
  Esophageal Cancer; Bile Duct Neoplasms; Gastric Cancer; Liver Cancer; Melanoma; Pancreatic Cancer; Sarcoma
  
• Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women With a Genetic Risk for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00082979 - Recruiting
  Breast Cancer
  
• Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
  ClinicalTrials.gov Identifier: NCT00003276 - Active, not recruiting
  recurrent gallbladder cancer; unresectable gallbladder cancer
  
• Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003411 - Completed
  stage III pancreatic cancer; stage IVB pancreatic cancer; stage II pancreatic cancer; unresectable gallbladder cancer; ...
  
• Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00513539 - Not yet recruiting
  Extrahepatic Bile Duct Cancer; Gallbladder Cancer
  
• Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer
  ClinicalTrials.gov Identifier: NCT00559598 - Not yet recruiting
  Extrahepatic Bile Duct Cancer; Pancreatic Cancer
  
• A Study of the WallFlex™ Biliary Fully-Covered Stent for the Palliative Treatment of Malignant Bile Duct Obstruction
  ClinicalTrials.gov Identifier: NCT00433771 - Recruiting
  Cholestasis, Extrahepatic
  
• Quality Of Life in Patients With Malignant Biliary Obstruction
  ClinicalTrials.gov Identifier: NCT00579865 - Completed
  Gallbladder Cancer; Liver Cancer; Bile Duct Cancer
  
• Clinical Feasibility Study of Allium's Biliary Stent
  ClinicalTrials.gov Identifier: NCT00448006 - Not yet recruiting
  Malignant Obstruction of the Common Bile Duct
  
• Compare Combined Sphincterotomy and Balloon Dilation (ESBD) Versus Standard Sphincterotomy (ES) in Removing Biliary Stones
  ClinicalTrials.gov Identifier: NCT00164853 - Recruiting
  Common Bile Duct Stone
  
• Breast Duct Lavage, Breast Duct Endoscopy, and Gene Expression Profiling in Women With Breast Cancer Compared With Healthy Women Who Are and Are Not at High Risk for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00070460 - Recruiting
  Breast Cancer
  
• Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00033735 - Active, not recruiting
  recurrent pancreatic cancer; duct cell adenocarcinoma of the pancreas
  
• Impact on Outcome of Early Endoscopic Extraction of Bile Duct Stones in Biliary Pancreatitis
  ClinicalTrials.gov Identifier: NCT00505128 - Not yet recruiting
  Biliary Pancreatitis
  
• R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00005832 - Active, not recruiting
  childhood gastrointestinal cancer; stage II pancreatic cancer; stage IVA pancreatic cancer; duct cell adenocarcinoma of the pancreas; ...
  
• Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00112528 - Active, not recruiting
  duct cell adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
  
• Evaluation of Breast Cancer Recurrence Rates Following Surgery for Ductal Carcinoma In Situ
  ClinicalTrials.gov Identifier: NCT00002934 - Active, not recruiting
  Breast Neoplasms; Carcinoma, Infiltrating Duct
  
• Nipple Aspiration, Ductal Lavage, and Duct Endoscopy For Diagnostic Assessment in Women Undergoing Surgery for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00083018 - Recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00003951 - Active, not recruiting
  recurrent pancreatic cancer; duct cell adenocarcinoma of the pancreas; stage IV pancreatic cancer; adenocarcinoma of the pancreas
  
• Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00058201 - Recruiting
  acinar cell adenocarcinoma of the pancreas; duct cell adenocarcinoma of the pancreas; stage I pancreatic cancer; stage II pancreatic cancer; ...
  
• Safety and efficacy study of IL-10 (Tenovil TM) in the prevention of Post-ERCP Acute Pancreatitis
  ClinicalTrials.gov Identifier: NCT00040131 - Terminated
  Bile Duct Diseases; Biliary Tract Diseases; Gallbladder Diseases; Pancreatitis; Pancreatic Diseases
  
• Study of Surgical Procedures for Treatment of Persistent Nasolacrimal Duct Obstruction in Children < 4 Years Old
  ClinicalTrials.gov Identifier: NCT00315315 - Recruiting
  Nasolacrimal Duct Obstruction
  
• Storage of Bile From Routine Procedures to Study Risk Factors
  ClinicalTrials.gov Identifier: NCT00414843 - Recruiting
  Gallbladder Cancer; Cholangiocarcinoma; Biliary Tract Cancer
  
• Breast Duct Lavage and Breast Duct Endoscopy for Detecting Breast Cancer
  ClinicalTrials.gov Identifier: NCT00028340 - Recruiting
  Breast Neoplasms; Healthy
  
• Biodegradable Biliary Stent for Post Operative Cystic Duct Leakage
  ClinicalTrials.gov Identifier: NCT00493675 - Recruiting
  Cystic Duct Leakage
  
• Randomized Study Assessing the Effect of Transpapillary Pancreas Duct Stent in Resection of the Pancreatic Tail
  ClinicalTrials.gov Identifier: NCT00500968 - Recruiting
  Pancreas Cancer; Fistula
  
• Nipple Aspiration, Ductal Lavage, and Duct Endoscopy in Screening Women at Moderate-to-High Risk of Developing Breast Cancer
  ClinicalTrials.gov Identifier: NCT00081003 - Recruiting
  Breast Cancer
  
• Pharmacokinetic Investigation of UDCA in Bile and Serum
  ClinicalTrials.gov Identifier: NCT00529009 - Recruiting
  Healthy
  
• Endoscopic Dacryocystorhinostomy Prospective Research
  ClinicalTrials.gov Identifier: NCT00571129 - Recruiting
  Lacrimal Duct Obstruction
  
• Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00004190 - Completed
  recurrent pancreatic cancer; stage IVA pancreatic cancer; duct cell adenocarcinoma of the pancreas; stage III pancreatic cancer; ...
  
• Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00052689 - Completed
  stage IVA pancreatic cancer; duct cell adenocarcinoma of the pancreas; stage IVB pancreatic cancer
  
• Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003018 - Completed
  childhood gastrointestinal cancer; stage II pancreatic cancer; duct cell adenocarcinoma of the pancreas; stage III pancreatic cancer
  
• Effects of Colesevelam HCl On Bile Acid Kinetics
  ClinicalTrials.gov Identifier: NCT00476710 - Recruiting
  Type 2 Diabetes Mellitus; Impaired Glucose Tolerance
  
• Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast
  ClinicalTrials.gov Identifier: NCT00165256 - Active, not recruiting
  Duct Carcinoma in Situ of the Breast
  
• Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00032175 - Completed
  stage III pancreatic cancer; duct cell adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Study of Primary Surgical Treatment of Nasolacrimal Duct Obstruction in Children Less Than Four Years Old
  ClinicalTrials.gov Identifier: NCT00315289 - Completed
  Nasolacrimal Duct Obstruction
  
• Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00006467 - Completed
  recurrent pancreatic cancer; stage IVA pancreatic cancer; duct cell adenocarcinoma of the pancreas; stage III pancreatic cancer; ...
  
• Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas
  ClinicalTrials.gov Identifier: NCT00084383 - Completed
  stage I pancreatic cancer; stage II pancreatic cancer; duct cell adenocarcinoma of the pancreas
  
• Zinc Supplements in Lowering Cadmium Levels in Smokers
  ClinicalTrials.gov Identifier: NCT00376987 - Active, not recruiting
  Bladder Cancer; Cervical Cancer; Esophageal Cancer; Gastric Cancer; Head and Neck Cancer; Kidney Cancer; Leukemia; Liver Cancer; Lung Cancer; Pancreatic Cancer; Tobacco Use Disorder
  
• Biological Therapy in Treating Patients With Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00004604 - Active, not recruiting
  Lung Cancer; Testicular Cancer; ovarian epithelial cancer; Pancreatic Cancer; Colon Cancer; Thyroid Cancer; Gastric Cancer; Salivary Gland Cancer; ...
  
• Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer
  ClinicalTrials.gov Identifier: NCT00287885 - Active, not recruiting
  Cervical Cancer; Endometrial Cancer; Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer; Sarcoma; Vaginal Cancer; Vulvar Cancer
  
• Gene Therapy in Treating Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00004178 - Active, not recruiting
  Lung Cancer; Pancreatic Cancer; Gastric Cancer; Salivary Gland Cancer; Renal Cell Cancer; Endometrial Cancer; Esophageal Cancer; Head and Neck Cancer; ...
  
• A Phase I Study of ECO-4601 in Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00338026 - Active, not recruiting
  Tumors; Glioma; Colorectal Cancer; Lung Cancer; Breast Cancer; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer
  
• Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors
  ClinicalTrials.gov Identifier: NCT00433602 - Active, not recruiting
  Breast Cancer; Colorectal Cancer; Gastric Cancer; Lung Cancer; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer; Thromboembolism
  
• The Revolutions of Helicobacter Pylori Infection, Bacterial Density, and Histological Features After Antrectomy
  ClinicalTrials.gov Identifier: NCT00441831 - Recruiting
  Helicobacter Pylori Infection; Peptic Ulcer; Bile Reflux; Gastritis
  
• Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
  ClinicalTrials.gov Identifier: NCT00003170 - Active, not recruiting
  Pancreatic Cancer; Vulvar Cancer; Renal Cell Cancer; Endometrial Cancer; Testicular Cancer; ovarian epithelial cancer; Colon Cancer; Rectal Cancer; ...
  
• Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
  ClinicalTrials.gov Identifier: NCT00268918 - Active, not recruiting
  Ovarian Cancer; Endometrial Cancer; Cervical Cancer; Fallopian Tube Cancer; Peritoneal Cancer; Breast Cancer
  
• Phase I Study of SU006668 in Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00024063 - Active, not recruiting
  Lung Cancer; Pancreatic Cancer; Gastric Cancer; Renal Cell Cancer; Colorectal Cancer; Colon Cancer; Prostate Cancer; Rectal Cancer; Breast Cancer; ...
  
• Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia
  ClinicalTrials.gov Identifier: NCT00056004 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Lung Cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer
  
• Irinotecan and Capecitabine in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003867 - Active, not recruiting
  Pancreatic Cancer; Gastric Cancer; Esophageal Cancer; Colorectal Cancer; adult primary liver cancer; Colon Cancer; Rectal Cancer; Breast Cancer
  
• Spectroscopy With Surface Coils and Decoupling
  ClinicalTrials.gov Identifier: NCT00581815 - Recruiting
  Adrenal Cortical Cancer; Brain Cancer; Breast Cancer; CNS Cancer; Colon Cancer; HEENT Cancer; Hodgkin's Disease; Kaposi's Sarcoma; Liver Cancer; Lung Cancer; Non-Hodgkin's Lymphoma; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer; Rectal Cancer; Renal Cancer; Sarcoma; Squamous Cell Carcinoma; Thyroid Cancer
  
• High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00002854 - Active, not recruiting
  Breast Cancer; Gastrointestinal Cancer; Kidney Cancer; Musculoskeletal Cancer; Reproductive Cancer; Skin Cancer
  
• Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004234 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of cancer and cancer therapy; ...
  
• Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer
  ClinicalTrials.gov Identifier: NCT00005049 - Active, not recruiting
  female reproductive cancer; Gastrointestinal Cancer; unclassified and other cancer
  
• Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer
  ClinicalTrials.gov Identifier: NCT00003427 - Active, not recruiting
  Pancreatic Cancer; Colon Cancer; Gastric Cancer; Rectal Cancer; Esophageal Cancer; Colorectal Cancer; adult primary liver cancer
  
• Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function
  ClinicalTrials.gov Identifier: NCT00005644 - Active, not recruiting
  Bladder Cancer; Cancer of the Renal Pelvis and Ureter; Gastrointestinal Cancer; Urethral Cancer
  
• Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
  ClinicalTrials.gov Identifier: NCT00002520 - Active, not recruiting
  Leukemia; Lymphoma; Head and Neck Cancer; Lung Cancer; Eye Cancer; Gastrointestinal Cancer; Oral Cancer; Reproductive Cancer
  
• Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity
  ClinicalTrials.gov Identifier: NCT00003548 - Active, not recruiting
  Gastrointestinal Cancer; Pancreatic Cancer; Liver Cancer; Female Reproductive Cancer
  
• Genetic Study of Patients and Families With a History of Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003648 - Active, not recruiting
  Colon Cancer; Gastrointestinal Cancer; Rectal Cancer
  
• A Telephone-Based Prevention Care Manager in Increasing Screening Rates for Breast Cancer, Cervical Cancer, and Colorectal Cancer in Minority and Low-Income Women
  ClinicalTrials.gov Identifier: NCT00376909 - Active, not recruiting
  Breast Cancer; Cervical Cancer; Colorectal Cancer
  
• Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction
  ClinicalTrials.gov Identifier: NCT00004910 - Active, not recruiting
  Pancreatic Cancer; Gastric Cancer; Colorectal Cancer; Colon Cancer
  
• Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis
  ClinicalTrials.gov Identifier: NCT00026468 - Active, not recruiting
  Colon Cancer; Rectal Cancer; small intestine cancer
  
• Diet and PSA Levels in Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003367 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...